You are here:
Home
> News
The latest news from dabl >
Dec 2011: Seasons Greetings from all at dabl Ltd
Aug 2011: NICE radically overhauls hypertension guidelines to include ABPM
New guidelines now recommend the use of 24-hr ABPM to diagnose hypertension.
Jul 2011: Prof Desmond Fitzgerald appointed to board of dabl Ltd
dabl Ltd is pleased to announce the appointment of Prof Desmond Fitzgerald MD, to the dabl Board of Directors.
Apr 2011: dabl shortlisted for another award
dabl has been shortlisted as a finalist of the 2011 Biomnis Healthcare Innovation Award.
Feb 2011: Draft NICE Guidelines recommend use of 24-hr ABPM
GPs in the UK are set for a huge change in the management of millions of patients with high blood pressure, after draft NICE guidelines recommended use of 24-hour ABPM to make all new diagnoses and guide treatment.
Jan 2011: dabl Ltd to exhibit at the 23rd DIA Annual Euromeeting in Geneva
dabl Ltd is pleased to announce that we will exhibit at the upcoming 23rd DIA Annual EuroMeeting (28-30 March 2010 in Geneva, Switzerland). Visit us at booth no. 1186
Jan 2011: Dedicated dabl Research website launched
dabl has launched a new dedicated website for clinical trials www.dablresearch.com.
dabl provides centralised Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) systems to assess the efficacy of investigational anti-hypertensive drugs and to monitor the cardiac safety of non-cardiovascular drugs.
About dabl Ltd
dabl Ltd is a leading developer and provider of expert healthcare management software systems and research tools for the prevention and management of stroke, heart attack, blood pressure, anticoagulation and a range of other cardiovascular conditions.